TY - JOUR
T1 - Inhibiting mechanotransduction prevents scarring and yields regeneration in a large animal model
AU - Mascharak, Shamik
AU - Griffin, Michelle
AU - Talbott, Heather E.
AU - Guo, Jason L.
AU - Parker, Jennifer
AU - Morgan, Annah Grace
AU - Valencia, Caleb
AU - Kuhnert, Maxwell Michael
AU - Li, Dayan J.
AU - Liang, Norah E.
AU - Kratofil, Rachel M.
AU - Daccache, Joseph A.
AU - Sidhu, Ikjot
AU - Davitt, Michael F.
AU - Guardino, Nicholas
AU - Lu, John M.
AU - Abbas, Darren B.
AU - Deleon, Nestor M.D.
AU - Lavin, Christopher V.
AU - Adem, Sandeep
AU - Khan, Anum
AU - Chen, Kellen
AU - Henn, Dominic
AU - Spielman, Amanda
AU - Cotterell, Asha
AU - Akras, Deena
AU - Mauricio Downer, M. D.
AU - Tevlin, Ruth
AU - Lorenz, H. Peter
AU - Gurtner, Geoffrey C.
AU - Januszyk, Michael
AU - Naik, Shruti
AU - Wan, Derrick C.
AU - Longaker, Michael T.
N1 - Publisher Copyright:
Copyright © 2025 The Authors, some rights reserved;
PY - 2025/2/19
Y1 - 2025/2/19
N2 - Modulating mechanotransduction by inhibiting yes-associated protein (YAP) in mice yields wound regeneration without scarring. However, rodents are loose-skinned and fail to recapitulate key aspects of human wound repair. We sought to elucidate the effects of YAP inhibition in red Duroc pig wounds, the most human-like model of scarring. We show that one-time treatment with verteporfin, a YAP inhibitor, immediately after wounding is sufficient to prevent scarring and to drive wound regeneration in pigs. By performing single-cell RNA sequencing (scRNA-seq) on porcine wounds in conjunction with spatial proteomic analysis, we found perturbations in fibroblast dynamics with verteporfin treatment and the presence of putative pro-regenerative/profibrotic fibroblasts enriched in regenerating/ scarring pig wounds, respectively. We also identified differences in enriched myeloid cell subpopulations after treatment and linked this observation to increased elaboration of interleukin-33 (IL-33) in regenerating wounds. Finally, we validated our findings in a xenograft wound model containing human neonatal foreskin engrafted onto nude mice and used scRNA-seq of human wound cells to draw parallels with fibroblast subpopulation dynamics in porcine wounds. Collectively, our findings provide support for the clinical translation of local mechanotransduction inhibitors to prevent human skin scarring, and they clarify a YAP/IL-33 signaling axis in large animal wound regeneration.
AB - Modulating mechanotransduction by inhibiting yes-associated protein (YAP) in mice yields wound regeneration without scarring. However, rodents are loose-skinned and fail to recapitulate key aspects of human wound repair. We sought to elucidate the effects of YAP inhibition in red Duroc pig wounds, the most human-like model of scarring. We show that one-time treatment with verteporfin, a YAP inhibitor, immediately after wounding is sufficient to prevent scarring and to drive wound regeneration in pigs. By performing single-cell RNA sequencing (scRNA-seq) on porcine wounds in conjunction with spatial proteomic analysis, we found perturbations in fibroblast dynamics with verteporfin treatment and the presence of putative pro-regenerative/profibrotic fibroblasts enriched in regenerating/ scarring pig wounds, respectively. We also identified differences in enriched myeloid cell subpopulations after treatment and linked this observation to increased elaboration of interleukin-33 (IL-33) in regenerating wounds. Finally, we validated our findings in a xenograft wound model containing human neonatal foreskin engrafted onto nude mice and used scRNA-seq of human wound cells to draw parallels with fibroblast subpopulation dynamics in porcine wounds. Collectively, our findings provide support for the clinical translation of local mechanotransduction inhibitors to prevent human skin scarring, and they clarify a YAP/IL-33 signaling axis in large animal wound regeneration.
UR - https://www.scopus.com/pages/publications/85218806374
U2 - 10.1126/scitranslmed.adt6387
DO - 10.1126/scitranslmed.adt6387
M3 - Article
C2 - 39970235
AN - SCOPUS:85218806374
SN - 1946-6234
VL - 17
JO - Science translational medicine
JF - Science translational medicine
IS - 786
M1 - eadt6387
ER -